An Update on COVID-19 Therapeutics (AAC ed.)

<p>COVID-19 continues to pose major problems in the winter in the USA. Infections and hospitalizations are increasing and there is a fear of emergence of new variants. Therapeutic tools are also evolving. We discuss these new developments!</p> <p>Watch the video version via: https://youtu.be/ElnahBl53e8</p> <h2><strong>Topics discussed:</strong></h2> <ul> <li>The latest facts on COVID</li> <li>Current therapeutic approaches including antivirals and monoclonal antibodies</li> <li>Future perspectives for the coming year on COVID-19.</li> </ul> <h2><strong>Guests:</strong></h2> <ul> <li>Adarsh Bhimraj, MD. Director of Education and Fellowships, Division of Infectious Diseases, Houston Methodsit Hospital. Chair IDSA Guidelines for COVID-19.</li> </ul> <p>This episode of Editors in Conversation is brought to you by the Antimicrobial Agents and Chemotherapy Journal and hosted by AAC Editor in Chief, Cesar Arias.</p> <p>AAC is available at https://asm.org/aac.</p> <p>Follow Cesar on twitter at https://twitter.com/SuperBugDoc for AAC updates.</p> <p>Subscribe to the podcast at https://asm.org/eic</p>